Bayer files for expanded use of Stivarga in liver cancer

Bayer has filed applications in Europe, the US and Japan seeking approval to expand the scope of its cancer drug regorafenib to include the second-line treatment of liver cancer.
Read the full story: PharmaTimes: News RSS